Evidence map›Paper›PMID 41216413›Full record

ArticleThe journal of allergy and clinical immunology. Global2026

Trends over a decade in the prevalence and eliciting dose of peanut and tree nut allergies in Japan.

Hitomi Kubota, Tatsuki Fukuie, Sayaka Hamaguchi, Seiko Hirai, Kenji Toyokuni, Kiwako Yamamoto-Hanada, Akira Ishiguro, Yukihiro Ohya

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hitomi KubotaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Tatsuki FukuieAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Sayaka HamaguchiAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Seiko HiraiAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Kenji ToyokuniAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Kiwako Yamamoto-HanadaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.
Akira IshiguroCenter for Postgraduate Education and Training, National Center for Child Health and Development, Tokyo, Japan.
Yukihiro OhyaAllergy Center, National Center for Child Health and Development, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of tree nuts allergy is rapidly increasing in Japan, yet the eliciting dose (ED) for tree nuts, particularly in Asian populations, has not been sufficiently investigated. Objective: This study aimed to quantify EDs for peanut, cashew nut, and walnut in Japanese patients with food allergies and to investigate longitudinal changes in these values. Methods: We retrospectively analyzed 1,275 oral food challenge results for patients with diagnosed peanut, cashew nut, or walnut allergy, conducted between November 2013 and December 2023 at a single allergy center. EDs were calculated using the Weibull, log-normal, and log-logistic models, and bivariate survival analysis was used to examine the relationship between allergen-specific IgE levels and ED causing reaction in 5% of the allergic population (ED Results: The ED Conclusions: EDs in Japanese tree nut-allergic populations are decreasingly aligned with those reported in Western countries, reflecting shifts in dietary habits and allergen exposure. The findings of the dynamic nature of threshold dose distributions over time, even within the same region, emphasize the necessity for periodic reassessment of allergen risk thresholds to ensure optimal patient safety.

Indexed as

Allergen-specific IgEdose distribution curveeliciting doseoral food challengetree nut allergy

Identifiers

PMID41216413
PMCPMC12597278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.